Continuous Manufacturing: From Innovation to Regulatory Reality
This session explored how pharma teams adopt continuous manufacturing using digital technologies and real-time monitoring, highlighting how FDA ETP enables compliant innovation.
Continuous manufacturing is transforming API production across development and commercial stages. This session highlighted how these systems operate within GxP frameworks, integrating quality, validation, and traceability to meet regulatory expectations.
The discussion focused on practical challenges including scalability, technology adoption, and regulatory alignment. It showcased how ETP engagement helps move from pilot setups to production-ready systems supporting compliance and quality.
Event at a Glance
Key metrices from our successful webinar session
177+
Registartions
47+
Unique viewers
1834
Minutes viewed
Featured Voices
Visionaries who led the conversation.
John Raech
President, Pharma Resource Group (PRG)
Nagesh Nama
Chief Executive Officer, xLM
60 Minutes of
Practical Insight
April 23, 2026
Full access session recording available on demand.
60 Minutes of Content
Focused discussion on continuous manufacturing, FDA ETP, and AI-driven pharma operations.
This LinkedIn Live session brought together industry leaders to explore how pharmaceutical organizations are adopting continuous manufacturing, advanced analytics, and digital-first approaches in alignment with the FDA’s Emerging Technology Program (ETP). Through PRG’s real-world journey, the discussion highlighted how early regulatory engagement, real-time process monitoring, and AI-driven quality insights can reduce risk, accelerate innovation, and build inspection-ready operations from the ground up.
Detailed Event Overview
This LinkedIn Live session explored how pharmaceutical organizations are advancing toward continuous manufacturing through digital technologies, real-time analytics, and AI-driven processes. Centered on PRG’s journey, it highlighted how early FDA ETP engagement helps navigate regulatory expectations while accelerating innovation and building inspection-ready operations.
Manufacturing & ETP Insights
This session featured expert perspectives on designing and scaling continuous flow manufacturing within regulated environments. The discussion focused on how organizations can leverage FDA’s ETP to de-risk adoption of emerging technologies while ensuring compliance, efficiency, and long-term scalability.
- Why early FDA engagement through ETP is critical for emerging technologies
- Challenges in transitioning from batch to continuous manufacturing systems
- Role of real-time monitoring and advanced analytics in process control
- How AI-driven insights enhance quality, consistency, and decision-making
- Building future-ready operations with integrated digital and compliance frameworks
A Glance at Our Online Event
Couldn't make it in person? Our hybrid model ensured that thousands joined us virtually. Experience the high-fidelity stream that brought the summit to living rooms worldwide.
Ready to Elevate Your Operations?
Don't let the momentum stop here. Leverage our expert consulting services to implement the strategies discussed at the summit and drive your business forward.